Activated human mast cells induce LOX-1-specific scavenger receptor expression in human monocyte-derived macrophages

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Alanne Kinnunen, Mervi ^a   Lappalainen, Jani ^a   Öörni, Katariina ^a   Kovanen, Petri T ^a  

^a WIHURI RESEARCH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; HISTAMINE; HISTAMINE H2 RECEPTOR; MACROPHAGE SCAVENGER RECEPTOR 1; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; SCAVENGER RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; MSR1 PROTEIN, HUMAN; OLR1 PROTEIN, HUMAN; SCAVENGER RECEPTOR A; TGFB1 PROTEIN, HUMAN;

ARTICLE; CD36 GENE; CELL ACTIVATION; CELLULAR SECRETION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOSTIMULATION; LOX 1 GENE; MACROPHAGE; MACROPHAGE FUNCTION; MAST CELL; MONOCYTE; MONOCYTE DERIVED MACROPHAGE; MSR1 GENE; PROTEIN EXPRESSION; PROTEIN TRANSPORT; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; IMMUNOLOGY; METABOLISM;

ANTIGENS, CD36; CELLS, CULTURED; HISTAMINE; HUMANS; MACROPHAGES; MAST CELLS; SCAVENGER RECEPTORS, CLASS A; SCAVENGER RECEPTORS, CLASS E; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84907456032     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108352     Document Type: Article

References (36)

1. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, et al. (2005) Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annual Review of Immunology 23: 749-786.
2. Halvorsen B, Otterdal K, Dahl TB, Skjelland M, Gullestad L, et al. (2008) Atherosclerotic plaque stability-what determines the fate of a plaque? Progress in Cardiovascular Diseases 51: 183-194.
3. Kovanen PT (2007) Mast cells: multipotent local effector cells in atherothrombosis. Immunological Reviews 217: 105-122.
4. Bot I, de Jager SC, Zernecke A, Lindstedt KA, van Berkel TJ, et al. (2007) Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice. Circulation 115: 2516-2525.
5. Lindstedt KA, Kovanen PT (2004) Mast cells in vulnerable coronary plaques: potential mechanisms linking mast cell activation to plaque erosion and rupture. Curr Opin Lipidol 15: 567-573.
6. Laine P, Kaartinen M, Penttila A, Panula P, Paavonen T, et al. (1999) Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation 99: 361-369.
7. Theoharides TC, Kempuraj D, Tagen M, Conti P, Kalogeromitros D (2007) Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev 217: 65-78.
8. Kaartinen M, Penttila A, Kovanen PT (1996) Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha. Circulation 94: 2787-2792.
9. Hansson GK, Robertson AK, Soderberg-Naucler C (2006) Inflammation and atherosclerosis. Annu Rev Pathol 1: 297-329.
10. Kunjathoor VV, Febbraio M, Podrez EA, Moore KJ, Andersson L, et al. (2002) Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem 277: 49982-49988.
11. Nozaki S, Kashiwagi H, Yamashita S, Nakagawa T, Kostner B, et al. (1995) Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J Clin Invest 96: 1859-1865.
12. Li L, Sawamura T, Renier G (2004) Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation. Circ Res 94: 892-901.
13. Tanimoto A, Murata Y, Nomaguchi M, Kimura S, Arima N, et al. (2001) Histamine increases the expression of LOX-1 via H2 receptor in human monocytic THP-1 cells. FEBS Lett 508: 345-349.
14. Hashizume M, Mihara M (2012) Atherogenic effects of TNF-alpha and IL-6 via up-regulation of scavenger receptors. Cytokine 58: 424-430.
15. Hofnagel O, Luechtenborg B, Stolle K, Lorkowski S, Eschert H, et al. (2004) Proinflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24: 1789-1795.
16. Hsu HY, Nicholson AC, Hajjar DP (1996) Inhibition of macrophage scavenger receptor activity by tumor necrosis factor-alpha is transcriptionally and post-transcriptionally regulated. J Biol Chem 271: 7767-7773.
17. Hsu HY, Twu YC (2000) Tumor necrosis factor-alpha-mediated protein kinases in regulation of scavenger receptor and foam cell formation on macrophage. J Biol Chem 275: 41035-41048.
18. Chu EM, Tai DC, Beer JL, Hill JS (2013) Macrophage heterogeneity and cholesterol homeostasis: classically-activated macrophages are associated with reduced cholesterol accumulation following treatment with oxidized LDL. Biochim Biophys Acta 1831: 378-386.
19. Draude G, Lorenz RL (2000) TGF-beta1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages. Am J Physiol Heart Circ Physiol 278: H1042-1048.
20. Kaakinen R, Lindstedt KA, Sneck M, Kovanen PT, Oorni K (2007) Angiotensin II increases expression and secretion of cathepsin F in cultured human monocyte-derived macrophages: an angiotensin II type 2 receptor-mediated effect. Atherosclerosis 192: 323-327.
21. Lappalainen J, Lindstedt KA, Kovanen PT (2007) A protocol for generating high numbers of mature and functional human mast cells from peripheral blood. Clin Exp Allergy 37: 1404-1414.
22. Dichlberger A, Schlager S, Lappalainen J, Kakela R, Hattula K, et al. (2011) Lipid body formation during maturation of human mast cells. J Lipid Res 52: 2198-2208.
23. Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP, et al. (2003) Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk Res 27: 677-682.
24. Kokkonen JO, Kovanen PT (1985) Low density lipoprotein degradation by rat mast cells. Demonstration of extracellular proteolysis caused by mast cell granules. J Biol Chem 260: 14756-14763.
25. R Development Core Team (2009) R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing.
26. Wang KY, Arima N, Higuchi S, Shimajiri S, Tanimoto A, et al. (2000) Switch of histamine receptor expression from H2 to H1 during differentiation of monocytes into macrophages. FEBS Lett 473: 345-348.
27. Triggiani M, Petraroli A, Loffredo S, Frattini A, Granata F, et al. (2007) Differentiation of monocytes into macrophages induces the upregulation of histamine H1 receptor. J Allergy Clin Immunol 119: 472-481.
28. Kohro T, Tanaka T, Murakami T, Wada Y, Aburatani H, et al. (2004) A comparison of differences in the gene expression profiles of phorbol 12-myristate 13-acetate differentiated THP-1 cells and human monocyte-derived macrophage. J Atheroscler Thromb 11: 88-97.
29. Hu C, Dandapat A, Sun L, Khan JA, Liu Y, et al. (2008) Regulation of TGFbeta1-mediated collagen formation by LOX-1: studies based on forced overexpression of TGFbeta1 in wild-type and lox-1 knock-out mouse cardiac fibroblasts. J Biol Chem 283: 10226-10231.
30. Arjuman A, Chandra NC (2013) Effect of IL-10 on LOX-1 expression, signalling and functional activity: an atheroprotective response. Diab Vasc Dis Res 10: 442-451.
31. Moore KJ, Freeman MW (2006) Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol 26: 1702-1711.
32. Campbell LA, Lee AW, Rosenfeld ME, Kuo CC (2013) Chlamydia pneumoniae induces expression of pro-atherogenic factors through activation of the lectin-like oxidized LDL receptor-1. Pathog Dis 69: 1-6.
33. Shibata T, Shimozu Y, Wakita C, Shibata N, Kobayashi M, et al. (2011) Lipid peroxidation modification of protein generates Nepsilon-(4-oxononanoyl)lysine as a pro-inflammatory ligand. J Biol Chem 286: 19943-19957.
34. Ding Z, Liu S, Wang X, Dai Y, Khaidakov M, et al. (2014) LOX-1, mtDNA damage, and NLRP3 inflammasome activation in macrophages: implications in atherogenesis. Cardiovasc Res.
35. Cominacini L, Fratta Pasini A, Garbin U, Nava C, Davoli A, et al. (2003) Nebivolol and its 4-keto derivative increase nitric oxide in endothelial cells by reducing its oxidative inactivation. J Am Coll Cardiol 42: 1838-1844.
36. Cominacini L, Rigoni A, Pasini AF, Garbin U, Davoli A, et al. (2001) The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide. J Biol Chem 276: 13750-13755.